Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 66 for “"Tranexamic acid"”.
-
Prophylactic tranexamic acid use in orthognathic surgery: a systematic review
… pharmaceutical adjunct in reducing blood loss is tranexamic acid (TXA). Tranexamic acid is a synthetic amino acid that reversibly inhibits plasminogen activation, which in turn prevents the breakdown of microclots and reduces blood loss. It is widely used and validated in other surgical procedures …
-
The Effect of Topical Tranexamic Acid Application on Melasma Treatment
… hyperpigmentary disorder mainly on the face. Tranexamic acid (TA), a plasmin inhibitor, has been suggested as an efficient treatment modality on melasma. The aim of this study was to investigate the effects and action mechanism of topical TA in the treatment of melasma. Material and methods: …
-
Outcome measures in clinical trials of tranexamic acid for bleeding
… Acute bleeding is a major public health problem. Tranexamic acid is an antifibrinolytic drug that reduces bleeding by inhibiting blood clot breakdown. Several clinical trials have assessed the effects of tranexamic acid for bleeding. To provide a valid and reliable estimate of the treatment …
-
Implementing the Use of Tranexamic Acid in the Acute Traumatically Injury Patient
Every year, traumatic injury accounts for more than five million deaths, and millions of more hospitalizations and emergency department visits worldwide. If the trauma patient does reach the hospital, more than half of those die from hemorrhage (Roberts, Shakur, Coats, et al., 2013) . A review of …
-
Tranexamic acid in trauma care : who should be treated, when and where?
Introduction: Early tranexamic acid (TXA) treatment reduces bleeding deaths in trauma patients. Guidelines recommend the use of TXA for trauma patients who are bleeding or who are at risk of significant haemorrhage within 3 hours of the injury. However, many trauma patients who might benefit from …
-
Tranexamic Acid Modulation of Excitatory and Inhibitory Amino Acid Receptors: A Potential Mechanism for Postoperative Seizures
Tranexamic acid (TXA) is an antifibrinolytic drug that is used worldwide to reduce blood loss in a variety of hemorrhagic conditions. TXA causes seizures and myoclonic spasms, particularly during the postoperative period, and these seizures are associated with a higher incidence of neurological …
-
To evaluate the safety and efficacy of intra-articular tranexamic acid in primary total joint arthoplasty
BACKGROUND: Tranexamic acid (TXA) has become highly utilized in total joint arthroplasties for its anti-fibrinolytic effect. Recently, intra-articular application of TXA has become popular for its avoidance of systemic distribution within the body. With a more direct application to the surgical …
-
Recommendations for the use of tranexamic acid and the risk in the management of acute bleeding during anesthesia /
… indications and recommendations for the use of tranexamic acid and its use in the management of acute bleeding without evaluating the risk in the management of acute bleeding. Excessive bleeding and blood loss are among the leading causes of mortality. In the management of acute bleeding, one …
-
Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a randomised trial.
Background: The CRASH-3 trial hypothesized that Tranexamic Acid (TXA) could reduce intracranial bleeding and the risk of head injury death in patients with traumatic brain injury (TBI). Because “head injury death” includes death from intracranial bleeding, to simplify the trial procedures, the …
-
Reducing transfusion while preserving Canada's blood supply: use of tranexamic acid in major non-cardiac surgeries at high-risk of transfusion
BACKGROUND: Tranexamic acid (TXA) inhibits fibrinolysis and has been shown to consistently reduce red blood cell (RBC) transfusion in cardiac and orthopedic surgery, where it is now incorporated into standard of care. Its efficacy and safety in other major surgeries at high risk of RBC transfusion …
-
Traneksaminės rūgšties panaudojimo rekomendacijos ir rizika valdant ūmų kraujavimą neurochirurgijoje anestezijos metu /
Tranexamic acid is increasingly used in surgical practice due to its haemostatic properties and favorable safety profile. The aim of this paper is to explore the potential of this drug in neurosurgery based on the latest evidence, and to compare current clinical guidelines, highlighting potential …
-
The Effect of Tranexamic Acid on Transfusion Requirement in Dual Antiplatelet-Treated Anemic Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery
… aim of this study was to evaluate the effect of tranexamic acid (TA) on blood loss and transfusion in preoperatively anemic patients who continued their dual antiplatelet therapy until within 5 days of off-pump CABG (OPCAB). Methods and Results: Seventy-six anemic patients were randomized into …
-
Evaluación costo-efectividad del uso del ácido tranexamico vs manejo convencional para reemplazo articular primario de rodilla y cadera en la Fundación Santa Fe de Bogotá durante el 2014-2015
… been developed, being one of these the use of tranexamic acid (TXA). Objective: To assess cost-effectiveness of tranexamic acid use in regard to not using it, in the reduction of bleeding and transfusion needs in patients who underwent primary total hip or knee arthroplasty, without an increase …
-
Effects of tranexamic acid on surgical, traumatic and obstetric bleeding: a critical analysis of the evidence from randomised trials using systematic reviews and meta-analytic techniques
… and morbidity. The antifibrinolytic drug, tranexamic acid (TXA), inhibits clot breakdown and may have a role in the management of excessive bleeding. AIM: Evaluate the evidence from randomised trials for the effects of TXA in patients with surgical bleeding, traumatic bleeding, and for …
-
Blood conservation in arthroplasty
… prevent bleeding, including antifibrinolytics (Tranexamic acid, Aprotinin and Epsilon-aminocaproic acid), Desmopressin, Recombinant factor VIIa and factor XIII, Fibrinogen, Fibrin sealants and non-fibrin sealants, however it is uncertain which of these drugs is most effective at preventing …
-
Factores predictores de crisis convulsivas en pacientes adultos en post operatorio de cirugías cardiovasculares en la fundación cardioinfantil
… 22 patients with seizures (18.1%) was not used tranexamic acid during surgery which has a statistical significance (p = 0.003) Conclusion: The use of tranexamic acid in the equipment of extra-corporeal circulation during such cardiovascular surgery may be a protective factor for the presentation …
-
Factores de riesgo para convulsiones tras cirugía cardiaca con acido tranexamico: estudio de casos y controles, FCI
… to blood products. Several reports suggest that tranexamic acid can induce seizure activity in the postoperative period. The objective of this study was to examine risk factors associated with postoperative seizures in patients undergoing cardiac surgery who received tranexamic acid. All patients …
-
Medidas de hemostasia local pós-exodontia unitárias em pacientes que fazem uso de varfarina: um estudo clínico controlado e randomizado
… irrigation, compress with gauze soaked with tranexamic acid and suture. The sample consisted of 37 patients with mean age of 45,5 years and 62,2% were female. After randomization 20 were allocated to the control group and 17 in the study group, and performed a surgical procedure per patient. …
Page 1 of 4